Patient engagement as a priority across clinical research
๐ ๐ฃ๐ฎ๐๐ถ๐ฒ๐ป๐ ๐ฒ๐ป๐ด๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐ ๐ถ๐ ๐ฏ๐ฒ๐ฐ๐ผ๐บ๐ถ๐ป๐ด ๐ฎ ๐ฝ๐ฟ๐ถ๐ผ๐ฟ๐ถ๐๐ ๐ฎ๐ฐ๐ฟ๐ผ๐๐ ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต.
But in our conversations with clinical operations, patient engagement, and real-world evidence teams, one challenge keeps coming up:
๐ ๐๐ผ๐ ๐ฑ๐ผ ๐๐ผ๐ ๐ถ๐ป๐๐ผ๐น๐๐ฒ ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐๐ ๐ฒ๐ฎ๐ฟ๐น๐ถ๐ฒ๐ฟ, ๐ถ๐ป ๐ฎ ๐๐ฎ๐ ๐๐ต๐ฎ๐ ๐ถ๐ ๐ฐ๐ผ๐บ๐ฝ๐น๐ถ๐ฎ๐ป๐, ๐๐๐ฟ๐๐ฐ๐๐๐ฟ๐ฒ๐ฑ, ๐ฎ๐ป๐ฑ ๐ฎ๐ฐ๐๐๐ฎ๐น๐น๐ ๐๐๐ฒ๐ณ๐๐น?
๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป๐ ๐๐ฒ ๐ต๐ฒ๐ฎ๐ฟ ๐ผ๐ณ๐๐ฒ๐ป:
โข How do we reach representative patient populations?
โข What does a high-quality patient panel actually look like?
โข Do we need ethics approval for patient surveys?
โข How do we stay GDPR-compliant when engaging patients directly?
Together with Stefan Gijssels - Patient Expert Center, weโre hosting an online session to share how pharma teams are addressing these questions in practice.
๐
Wednesday April 22 โ 9AM CET
๐ฏ Focus: practical approaches, real examples, and open discussion
If you're currently working on patient engagement (or planning upcoming studies), this will be highly relevant.